JHVEPhoto
Medtronic (NYSE:MDT) is a developer and manufacturer of medical devices for cardiac, neuroscience, surgery, and diabetes. MDT has revenue exposure diversified across countries and has maintained its R&D budgets equal to or higher than its revenue growth. In other words, MDT prioritizes product
If you enjoyed this article and want more direct access to my research and ideas as well as the chance to chat with me and review my two model portfolios (dividend and long-only total return stocks) and my overall investing strategy, please note that my Marketplace Service called Equanimity Research is now live. I am very excited to foster a community of like-minded investors. You can now sign up for a two-week free trial* and there is a considerable discount for early annual subscribers.
*Free trial only valid for first-time subscribers.